NCT07032649View on ClinicalTrials.gov

Evaluating Benzoyl Peroxide for Preventing Recurrence of HSV-1 Outbreaks With Rescue Crossover Option

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

January 31, 2027

Study Completion Date

July 31, 2027

Conditions
HSV
Interventions
DRUG

Benzoyl Peroxide 10% Bar

Active ingredient for drug included. Blind identification by package number

OTHER

Placebo

Placebo that looks like active treatment, blinded but available to ID via package number

Trial Locations (1)

30809

Zoom Health, Telehealth Only, Evans

All Listed Sponsors
lead

Greg Bew

INDUSTRY